NCT03356392Recruiting
German Stroke Registry - Endovascular Treatment
Source: ClinicalTrials.gov · Last updated 11 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 22 Nov 2017
- Start date
- Jun 2015
- Primary completion date
- Jun 2027
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Diseases
- Stroke
- NCT number
- NCT03356392
What you commit to
- Study type: Observational
- Planned participants: 10000
- From Jun 2015 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Clinical diagnosis of acute ischemic stroke
- Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset
- Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms
- Age \>18 years
- Ethic approval in process
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Hamburg-Eppendorf (UKE) Coordinator of this site? Confirm its status | Hamburg | Germany | Recruiting |
Related publications
- Nimodipine in catheter flush solutions is associated with reduced vasospasm risk in endovascular stroke treatment.J Neurointerv Surg · 2026 · PMID 42728086
- Impact of Severe Prestroke Disability on Outcomes After Mechanical Thrombectomy: A Multicenter Analysis.Stroke Vasc Interv Neurol · 2026 · PMID 41816510
- One-Stop Management Improves Outcome for Large Vessel Occlusion Stroke.Stroke Vasc Interv Neurol · 2026 · PMID 41816517
This page is information, not medical advice. Discuss any trial with your doctor.